Hostname: page-component-cd9895bd7-7cvxr Total loading time: 0 Render date: 2024-12-27T09:08:00.923Z Has data issue: false hasContentIssue false

Clozapine treatment, eosinophilia and agranulocytosis

Published online by Cambridge University Press:  03 January 2018

P. Bailey*
Affiliation:
Secteur VIII Centre, Hospitalier Spécialisé, F-68250 Rauffach, France
Rights & Permissions [Opens in a new window]

Abstract

Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Columns
Copyright
Copyright © 1997 The Royal College of Psychiatrists 

References

Amital, D., Gross, R., Amital, H., et al (1997) Coexistence of eosinophilia and agranulocytosis in a clozapine-treated patient (letter). British Journal of Psychiatry, 170, 194.Google Scholar
Banov, M. D., Tohen, M. & Friedberg, J. (1993) High risk of eosinophilia in women treated with clozapine. Journal of Clinical Psychiatry, 54, 466469.Google Scholar
Claghorn, J., Honigfeld, G., Abuzzahab, F. S., et al (1987) The risks and benefits of clozapine versus chlorpromazine. Journal of Clinical Psychopharmacology, 7, 377384.Google Scholar
Gerlach, J., Jorgensen, E. O. & Peacock, L. (1989) Long-term experience with clozapine in Denmark: research and clinical practice. Psychopharmacology, 99 (suppl.), S92S96.Google Scholar
Hummer, M., Kurz, M., Barnas, C., et al (1994) Clozapine-induced transient white blood count disorders. Journal of Clinical Psychiatry, 55, 429432.Google Scholar
Pere, J. J., Chaumet-Riffaud, R. D., Bourdeix, I., et al (1992) La clozapine (Leponex) en France. L'Encéphale, 18, 427432 Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.